Find your next paid study

University of North Carolina, Chapel HillNCT06331052

Actual pay is set by the research site.

Leveraging AI to Transform Dietary Choices for Cardiovascular Health in Young Adults Experiencing Food Insecurity

The goal of this feasibility study is to determine the adherence, acceptability, and usability of the behavioral intervention of a mobile AI application and it…

Healthy

University of California, DavisNCT07108452

Actual pay is set by the research site.

Acculturative StressMental Health

Piloting a Learning Collaborative for School-Based Bilingual Providers Delivering Evidence-Based Interventions

This pilot feasibility trial is designed to evaluate an adapted Learning Collaborative (LC) as an implementation strategy to support delivery of the Supporting…

University of OregonNCT07471633

Actual pay is set by the research site.

Phase 2

A Randomized, Double-blind, Placebo-controlled Clinical Trial to Assess the Efficacy and Safety of Magnesium Vitamin B6 in Combination With Treatment as Usual in First Episode of Bipolar I Disorder

This is a randomized, double-blind, placebo-controlled proof-of-concept clinical trial to assess the efficacy and safety of Magnesium-vitamin B6in combination …

Bipolar I DisorderDepression, AnxietyStress

Mclean HospitalNCT05837104

~$75 – $2,000

Actual pay is set by the research site.

Phase 3

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD

This study is evaluating the safety and efficacy of TSND-201 in adults with PTSD. Eligible participants will enter a 4-week Treatment Period where they will be…

Post Traumatic Stress Disorder

Transcend TherapeuticsNCT07836647

~$50 – $2,100

Actual pay is set by the research site.

ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions (ANGEL)

This prospective, blinded, single-arm study aims to test the performance of nanomechanical phenotype in predicting tumor type, tumor aggressiveness, and neoadj…

Breast Cancer

~$10 – $1,050

Actual pay is set by the research site.

ARTIDIS AGNCT06085833

Postpartum Preeclampsia Early Detection and Treatment: Using Biomarkers to Implement Risk-stratified Intervention (Nepal Pilot Randomized Controlled Trial)

The goal of this study is to address the significant morbidity associated with preeclampsia diagnosed after delivery. All participants will undergo biomarker e…

Postpartum Preeclampsia

Medical College of WisconsinNCT07185204

Actual pay is set by the research site.

Phase 1

A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)

Phase 1 dose escalation will determine the first cycle dose-limiting toxicities (DLTs), the maximum tolerated dose (MTD), the biologically effective dose and r…

Locally Advanced Solid TumorsMetastatic Solid Tumors

Turning Point Therapeutics, Inc.NCT03093116

~$150 – $4,200

Actual pay is set by the research site.

Prostate Tissue Biobank for People at Genetic Risk for Aggressive Disease

Prostate cancer is also the most common cancer in men with inherited pathogenic variants in BRCA1 and BRCA2. Beyond BRCA1/2, other genes are known to increase …

Prostate CancerGenetic Predisposition

Abramson Cancer Center at Penn MedicineNCT06659614

Actual pay is set by the research site.

Phase 1

Phase I/Ib, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM54 Administered Intravenously to Patients With Selected Advanced Solid Tumors.

The first part of the study (phase Ia - dose escalation) will evaluate the safety and tolerability and identify the dose-limiting toxicities (DLTs) of PM54. T…

Advanced Solid Tumor

Nonsmall Cell Lung CancerPerformance Status

~$150 – $4,200

Actual pay is set by the research site.

PharmaMarNCT05841563

Phase 2

Phase II Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-Small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

This pilot study is configured as a non-inferiority comparison of Performance Status 2 patients with Performance Status 0-1 patients, with the goal of demonstr…

Wake Forest University Health SciencesNCT04253964

~$75 – $2,000

Actual pay is set by the research site.

Phase 3

A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase 3 Study of Intra-Articular Administration of an Allogeneic Human Placental Tissue Particulate (PTP-001) for the Treatment of Knee Osteoarthritis

This is a multicenter, prospective, randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of intra-articular administration of PTP-001 (MOT…

Knee Osteoarthritis